Literature DB >> 31462553

Evaluation of Oxacillin and Cefoxitin Disk Diffusion and Microbroth Dilution Methods for Detecting mecA-Mediated β-Lactam Resistance in Contemporary Staphylococcus epidermidis Isolates.

Samia N Naccache1, Katrina Callan2, C A Burnham3, Meghan A Wallace3, Lars F Westblade2,4, Jennifer Dien Bard.   

Abstract

Methicillin (β-lactam) resistance in Staphylococcus epidermidis is mediated by the mecA gene, with resistance reported to be as high as 90%. The goal of this study was to evaluate oxacillin and cefoxitin disk diffusion (DD) and broth microdilution (BMD) methods for the detection of mecA-mediated β-lactam resistance in 100 human isolates of S. epidermidis (48 mecA-positive isolates and 52 mecA negative isolates). Oxacillin DD tests using the Clinical and Laboratory Standards Institute (CLSI) M100-S28 breakpoints for S. pseudintermedius/S. schleiferi accurately differentiated mecA-positive and -negative S. epidermidis isolates, with categorical agreement (CA) of 100% and no very major errors (VMEs) or major errors (MEs) identified. Likewise, oxacillin BMD and cefoxitin DD tests using the coagulase-negative Staphylococcus species (CoNS) breakpoints were highly reliable for detecting mecA-mediated β-lactam resistance in S. epidermidis isolates. For cefoxitin DD and BMD results interpreted using S. aureus/S. lugdunensis breakpoints, the CA was 97.6% and 96.2%, respectively. There were 4.9% VMEs for cefoxitin DD with 0% MEs, and 3.6% VMEs and 3.9% MEs for cefoxitin BMD. Oxacillin BMD using S. aureus/S. lugdunensis breakpoints yielded the highest VMEs at 17.4% and 90% CA. Our findings demonstrate that oxacillin DD tests using the CLSI M100-S28 breakpoints for S. pseudintermedius/S. schleiferi and oxacillin BMD and cefoxitin DD tests using the CoNS breakpoints reliably identified mecA-mediated β-lactam resistance in S. epidermidis Using mecA PCR as the gold standard, the PBP2a SA culture colony test (Abbott Diagnostics) exhibited 100% sensitivity and specificity whereas 2 false negatives were identified using the PBP2' latex agglutination test kit (Thermo Fisher Scientific) with sensitivity and specificity of 95.8% and 100%, respectively.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  MIC; PBP2a; Staphylococcus epidermidiszzm321990; broth microdilution; cefoxitin; disk diffusion; mecAzzm321990; methicillin-resistant Staphylococcus epidermidiszzm321990; oxacillin

Year:  2019        PMID: 31462553      PMCID: PMC6879287          DOI: 10.1128/JCM.00961-19

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Rapid detection of mecA-positive and mecA-negative coagulase-negative staphylococci by an anti-penicillin binding protein 2a slide latex agglutination test.

Authors:  Z Hussain; L Stoakes; S Garrow; S Longo; V Fitzgerald; R Lannigan
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Rapid detection of methicillin resistance in coagulase-negative staphylococci by a penicillin-binding protein 2a-specific latex agglutination test.

Authors:  M A Horstkotte; J K Knobloch; H Rohde; D Mack
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

3.  Evaluation of Oxacillin and Cefoxitin Disk Diffusion and MIC Breakpoints Established by the Clinical and Laboratory Standards Institute for Detection of mecA-Mediated Oxacillin Resistance in Staphylococcus schleiferi.

Authors:  H K Huse; S A Miller; S Chandrasekaran; J A Hindler; S D Lawhon; D A Bemis; L F Westblade; R M Humphries
Journal:  J Clin Microbiol       Date:  2018-01-24       Impact factor: 5.948

4.  Improved Performance of a Rapid Immunochromatographic Assay for Detection of PBP2a in Non-Staphylococcus aureus Staphylococcal Species.

Authors:  Matthew C Canver; Mark D Gonzalez; Bradley A Ford; Amanda R Arnold; Sara D Lawhon; C A Burnham; Stephen G Jenkins; Eileen M Burd; Lars F Westblade
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

5.  Results of disk diffusion testing with cefoxitin correlate with presence of mecA in Staphylococcus spp.

Authors:  Jana M Swenson; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

6.  Prevalence of molecular types and mecA gene carriage of coagulase-negative Staphylococci in a neonatal intensive care unit: relation to nosocomial septicemia.

Authors:  T G Krediet; M E Jones; K Janssen; L J Gerards; A Fleer
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

7.  Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period.

Authors:  Anna Conen; Laura Naemi Walti; Adrian Merlo; Ursula Fluckiger; Manuel Battegay; Andrej Trampuz
Journal:  Clin Infect Dis       Date:  2008-07-01       Impact factor: 9.079

8.  Evaluation of Oxacillin and Cefoxitin Disk and MIC Breakpoints for Prediction of Methicillin Resistance in Human and Veterinary Isolates of Staphylococcus intermedius Group.

Authors:  M T Wu; C-A D Burnham; L F Westblade; J Dien Bard; S D Lawhon; M A Wallace; T Stanley; E Burd; J Hindler; R M Humphries
Journal:  J Clin Microbiol       Date:  2015-11-25       Impact factor: 5.948

9.  Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene.

Authors:  B Hellmark; M Unemo; A Nilsdotter-Augustinsson; B Söderquist
Journal:  Clin Microbiol Infect       Date:  2009-01-22       Impact factor: 8.067

10.  In vitro activity of tedizolid and linezolid against Staphylococcus epidermidis isolated from prosthetic joint infections.

Authors:  C Littorin; B Hellmark; Å Nilsdotter-Augustinsson; B Söderquist
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-22       Impact factor: 3.267

View more
  7 in total

1.  Tailoring Antimicrobial Susceptibility Testing to Individual Species of Coagulase-Negative Staphylococci: Next Up, Staphylococcus epidermidis.

Authors:  C Paul Morris; Patricia J Simner
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

Review 2.  Overview of Changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition.

Authors:  Romney Humphries; April M Bobenchik; Janet A Hindler; Audrey N Schuetz
Journal:  J Clin Microbiol       Date:  2021-09-22       Impact factor: 5.948

3.  Susceptibility Testing by Volatile Organic Compound Detection Direct from Positive Blood Cultures: A Proof-of-Principle Laboratory Study.

Authors:  Sacha Daniëlle Kuil; Soemeja Hidad; Caroline Schneeberger; Pragya Singh; Paul Rhodes; Menno Douwe de Jong; Caroline Elisabeth Visser
Journal:  Antibiotics (Basel)       Date:  2022-05-24

4.  Commentary: Can Automated Blood Culture Systems Be Both New and Improved?

Authors:  Blake W Buchan
Journal:  J Clin Microbiol       Date:  2022-04-04       Impact factor: 11.677

5.  Comparison of rapid and conventional methods for investigating of mecA presence in Staphylococcus Species.

Authors:  Selim Gorgun; Hacer Isler; Mehmet Cenk Turgut
Journal:  Pak J Med Sci       Date:  2021 Sep-Oct       Impact factor: 1.088

6.  It's Not You, It's SOSA: A Case Study on Breaking Up With an FDA-Cleared Susceptibility Testing System's Oxacillin Results for Staphylococcus spp. Other Than S. aureus and S. lugdunensis.

Authors:  Christine Yang; Melis N Anahtar; Virginia M Pierce
Journal:  Open Forum Infect Dis       Date:  2022-08-17       Impact factor: 4.423

7.  Hindsight Is 2019-the Year in Clinical Microbiology.

Authors:  Matthew A Pettengill
Journal:  Clin Microbiol Newsl       Date:  2020-05-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.